Telepsychiatry Services and Provider Directory

Telepsychiatry applies video conferencing, asynchronous messaging, and remote monitoring technologies to the delivery of psychiatric evaluation, diagnosis, medication management, and psychotherapy. This page defines the scope of telepsychiatry as a clinical subspecialty of telehealth, explains its operational mechanisms, maps the regulatory frameworks governing practice, and clarifies the decision boundaries that determine when remote psychiatric care is clinically and legally appropriate. The information draws on published guidance from federal agencies including SAMHSA, CMS, and the DEA, as well as professional standards from the American Psychiatric Association.


Definition and scope

Telepsychiatry is the provision of psychiatric services — including diagnostic assessment, pharmacological management, psychotherapy, and crisis intervention — through technology-mediated channels rather than in-person clinical encounters. The American Psychiatric Association (APA) Telepsychiatry Toolkit identifies two primary modalities: synchronous telepsychiatry, conducted in real time via live audio-video, and asynchronous telepsychiatry, involving the recorded or written exchange of clinical information reviewed at a later time. A third variant, store-and-forward consultation, transmits clinical documents, behavioral assessments, and collateral history to a remotely located psychiatrist who produces a consultation report without a live encounter.

The scope of telepsychiatry overlaps substantially with, but is distinct from, general telehealth mental health and behavioral services. Telepsychiatry specifically involves a licensed psychiatrist (MD or DO with board certification or eligibility in psychiatry) and may include the prescriptive authority that non-physician behavioral health providers cannot exercise. Psychologists, licensed clinical social workers, and licensed professional counselors delivering talk therapy remotely fall under behavioral telehealth rather than telepsychiatry proper, though integrated programs frequently combine both.

Subspecialty telepsychiatry programs include:


How it works

A telepsychiatry encounter follows a structured sequence governed by state medical licensing law, federal prescribing regulations, and payer billing rules. The process subdivides into five discrete phases:

  1. Patient eligibility and access verification — The treating facility or platform confirms the patient holds a qualifying diagnosis or presenting complaint, meets payer criteria, and is located in a state where the consulting psychiatrist holds an active license. Telehealth licensure and interstate practice rules directly constrain which psychiatrists can serve which patients.

  2. Informed consent and privacy disclosure — Federal HIPAA requirements and most state laws require documented informed consent specific to telehealth before the encounter. CMS Conditions of Participation (42 CFR §482.13) extend informed consent obligations to hospital-based telepsychiatry programs. The platform must meet HIPAA Security Rule standards under 45 CFR Part 164.

  3. Clinical encounter — The psychiatrist conducts a live audio-video session or reviews asynchronous intake materials. Mental status examination, risk assessment (including validated tools such as the Columbia Suicide Severity Rating Scale), and medication review are completed. The 2022 SAMHSA publication Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders describes clinical fidelity benchmarks for remote psychiatric encounters.

  4. Prescribing and medication management — Controlled substance prescribing via telemedicine remains subject to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. §831) and DEA regulations at 21 CFR Part 1300. The DEA's 2023 proposed rules on telemedicine prescribing of controlled substances introduced registration requirements for remote prescribers, though final implementation timelines shifted following public comment periods.

  5. Documentation and billing — Encounters are documented in the EHR consistent with standard psychiatric visit codes. CMS reimburses telepsychiatry under the Medicare Physician Fee Schedule using Place of Service code 02 (telehealth) or 10 (telehealth in patient's home). CPT codes 90791 (psychiatric diagnostic evaluation), 90792 (with medical services), and 99213–99215 (evaluation and management) apply depending on encounter type and complexity.


Common scenarios

Telepsychiatry is deployed across four primary operational models:

Hub-and-spoke consultation places the consulting psychiatrist at a central hub institution while patients receive care at spoke sites — rural hospitals, federally qualified health centers, or primary care clinics. This model addresses geographic maldistribution; HRSA data indicate that more than 160 million people in the United States live in federally designated Mental Health Professional Shortage Areas (HRSA Shortage Area Data).

Direct-to-consumer (DTC) telepsychiatry connects individual patients to psychiatrists through dedicated platforms accessed from home or any internet-connected location. Oversight of DTC platforms intersects with FTC consumer protection authority and state medical board enforcement.

Collaborative care integration embeds telepsychiatry into the Collaborative Care Model (CoCM), a CMS-reimbursed team-based framework (billing under HCPCS G0502–G0505) that positions a consulting psychiatrist as a remote team member reviewing patient registries and advising primary care providers.

Inpatient and emergency department consultation uses real-time video to provide psychiatric triage in emergency settings, reducing patient boarding time in facilities without on-site psychiatric coverage.


Decision boundaries

Not all psychiatric presentations are appropriate for telepsychiatric management. The APA Telepsychiatry Task Force identifies clinical and logistical contraindications that clinicians and institutions must evaluate:

Regulatory boundaries are equally determinative. A psychiatrist licensed only in State A cannot legally treat a patient located in State B absent a second license, a compact authorization under the Interstate Medical Licensure Compact, or a federal exception (such as VA-to-patient telehealth under 38 U.S.C. §1730C). State-specific rules on telehealth prescribing laws and limits further modify what controlled substances may be initiated remotely and under what conditions. Payer rules under telehealth Medicaid coverage by state vary across all 50 states and the District of Columbia, requiring facility-level verification before service delivery.


References

📜 4 regulatory citations referenced  ·  🔍 Monitored by ANA Regulatory Watch  ·  View update log

Explore This Site